Nasdaq Adds Seven Companies to its Biotech Index | GenomeWeb

NEW YORK, Nov. 12 – The Nasdaq has added seven companies to its Nasdaq Biotechnology Index, bringing the number of companies in the index to 72.

The companies to be added to the index include Albany Molecular Research, Corixa, Genta, Immunomedics, Isis Pharmaceuticals, Invitrogen, and genomics company Exelixis.

The change in the index will be effective at the start of trading on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.